創始于1938年,專注于醫藥及保健產品的生產、分銷及零售的大型綜合醫藥公司,產品組合包括化學藥品/中藥/生物制劑以及營養保健品
華潤醫藥集團有限公司(香港聯合交易所股份代碼:3320.HK)是中國領先的綜合醫藥公司,業務范疇覆蓋醫藥及保健產品的生產、分銷及零售。自上市以來,華潤醫(yi)藥集已(yi)獲納(na)入(ru)多(duo)個重要(yao)資本市場指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu),包括:恒生(sheng)(sheng)綜(zong)合大型股(gu)(gu)指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)成份股(gu)(gu)、恒生(sheng)(sheng)中(zhong)(zhong)國(guo)內(nei)地醫療(liao)(liao)保(bao)健指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)、恒生(sheng)(sheng)醫療(liao)(liao)保(bao)健指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)、富時(shi)全(quan)(quan)球股(gu)(gu)票(piao)指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)(大型股(gu)(gu))、富時(shi)環球指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)、富時(shi)全(quan)(quan)球指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)全(quan)(quan)指(zhi)(zhi)(zhi)(zhi)(zhi)、摩根士丹利資本國(guo)際(MSCI)中(zhong)(zhong)國(guo)指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)成份股(gu)(gu)、恒生(sheng)(sheng)港股(gu)(gu)通(tong)指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)、恒生(sheng)(sheng)港股(gu)(gu)通(tong)中(zhong)(zhong)國(guo)內(nei)地公(gong)司指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)、恒生(sheng)(sheng)港股(gu)(gu)通(tong)非AH股(gu)(gu)公(gong)司指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)以及恒生(sheng)(sheng)港股(gu)(gu)通(tong)新經濟指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(shu)(shu)系列(lie)。
華潤醫藥集(ji)旗下擁有(you)華潤(run)醫藥(yao)(yao)(yao)商業集團有(you)限(xian)(xian)(xian)公(gong)(gong)司(si)、華潤(run)三九(jiu)醫藥(yao)(yao)(yao)股(gu)(gu)份(fen)有(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(000999.SZ)、華潤(run)雙鶴藥(yao)(yao)(yao)業股(gu)(gu)份(fen)有(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(600062.SH)、華潤(run)江中制藥(yao)(yao)(yao)集團有(you)限(xian)(xian)(xian)責任(ren)公(gong)(gong)司(si)、東阿(a)阿(a)膠股(gu)(gu)份(fen)有(you)限(xian)(xian)(xian)公(gong)(gong)司(si)(000423.SZ)、華潤(run)紫竹藥(yao)(yao)(yao)業有(you)限(xian)(xian)(xian)公(gong)(gong)司(si)、華潤(run)生物醫藥(yao)(yao)(yao)有(you)限(xian)(xian)(xian)公(gong)(gong)司(si)、中國醫藥(yao)(yao)(yao)研究開發中心有(you)限(xian)(xian)(xian)公(gong)(gong)司(si)等企業。
2020年,華潤醫藥(yao)集(ji)團實現(xian)營(ying)業收入2004.23億(yi)港幣,年內利(li)潤53.24億(yi)港幣。
華潤醫(yi)藥(yao)集的制造業務涵蓋研發、生產及銷售醫藥產品。產品組合包括化學藥品、中藥、生物制劑以及營養保健品,覆蓋廣泛治療領域,包括心血管、消化道和新陳代謝、大容量靜脈輸注、兒科、呼吸系統等。此外,華潤醫藥集擁有多個品牌,包括(kuo)“三九”、“東阿阿膠”、“雙(shuang)鶴”、“江中(zhong)”及“紫竹”。
華潤(run)醫藥集經營著一個由176個物流中心構成的全國性分銷網絡,戰略性覆蓋中國28個省、直轄市及自治區。憑借產品供應及廣泛的分銷網絡,華潤醫藥集向中國醫院及其他醫療機構直接分銷產品。另外,華潤醫藥集經營中國大型零售藥房網絡之一,華(hua)潤醫藥集(ji)以“華潤堂”、“醫保(bao)全新”、“禮安連鎖(suo)”和“同德堂”等全國或地(di)區(qu)性的(de)品牌來經營862家自(zi)營零(ling)售藥房。
“守護人類健康 提升生命質量”是華(hua)潤醫(yi)藥集(ji)的崇高使命。華潤醫藥集立足(zu)中(zhong)國醫藥健康(kang)(kang)產業(ye)發(fa)(fa)展和變革機遇,積極布局產業(ye)鏈的(de)核(he)心(xin)(xin)領(ling)域(yu)和核(he)心(xin)(xin)環節,堅持創新發(fa)(fa)展,充分(fen)發(fa)(fa)揮一體化(hua)業(ye)務布局的(de)協(xie)同效應,優化(hua)資(zi)源(yuan)配置,加強國際合(he)作(zuo),推(tui)動轉型(xing)升(sheng)級,持續提(ti)升(sheng)核(he)心(xin)(xin)競爭力,致力于(yu)成(cheng)為(wei)中(zhong)國醫藥健康(kang)(kang)產業(ye)的(de)引導者。